U.S., June 3 -- ClinicalTrials.gov registry received information related to the study (NCT07621068) titled 'Hyperbaric Oxygen Therapy for Chronic Fatigue Syndrome (CFS)' on May 19.
Brief Summary: This study evaluates the effects of hyperbaric oxygen therapy (HBOT) in patients with mild to moderate CFS/ME. Participants will undergo 60 HBOT sessions over 3 months with a 3-month follow-up, including physical, cognitive, imaging, and laboratory assessments.
Study Start Date: June, 2026
Study Type: INTERVENTIONAL
Condition:
Chronic Fatigue Syndrome
Intervention:
DEVICE: Hyperbaric oxygen therapy
60 consecutive sessions of breathing 100% oxygen by mask at 2 ATA for 90 minutes with 5-minute air breaks every 20 minutes, 5 sessions per week ...